Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma
Kasili, E.G.
East African Medical Journal 53(9): 554-559
1976
ISSN/ISBN: 0012-835X PMID: 1009883 Document Number: 109879
Document emailed within 1 workday
Related Documents
Sezaki, T. 1989: Current results of chemotherapy in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 1997-2003Hiddemann, W. 1996: Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy Therapeutische Umschau. Revue Therapeutique 53(2): 123-132
Macey, M.G. 1993: Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas British Journal of Biomedical Science 50(4): 334-349
Tribalto, M.; Arcese, W.; Colombo, R.; Pastore, S.; Franchii, A. 1981: Chemotherapy of multiple myeloma. Review of the recent trials Recenti Progressi in Medicina 71(2): 141-147
Thomas, P.J.; Daban, A.; Bontoux, D. 1984: Double hemibody irradiation in chemotherapy-resistant multiple myeloma Cancer Treatment Reports 68(9): 1173-1175
Alexanian, R.; Migliore, P.J. 1970: Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy Journal of Laboratory and Clinical Medicine 75(2): 225-233
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Alberts, D.S.; Golde, D.W. 1974: DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy Cancer Research 34(11): 2911-2914
Bataille, R.; Morlock, G.; Rosenberg, F.; Sany, J.; Serre, H. 1979: Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(31-32): 1377-1382
Kurihara, K.; Hill, W.; Burkhardt, R.; Kettner, G.; Hashimoto, N. 1987: Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(4): 876-889
Kazimierska, E.; Górski, J. 1989: Anti-HBS, anti-CMV, and anti-HIV antibodies and HBS antigen in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma Acta Haematologica Polonica 20(2): 189-194
Li, J.; Zhao, Y.; Luo, S.-K.; Huang, B.-H.; Zhang, G.-C.; Peng, A.-H.; Zheng, D.; Su, C.; Xu, D.-R.; Tong, X.-Z.; Gu, J.-L.; Ding, Y. 2008: The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma Zhonghua Yi Xue Za Zhi 88(30): 2140-2143
Bergogne-Berezin, E. 1980: Current trends in antibacterial chemotherapy La Nouvelle Presse Medicale 9(39): 2909-2914
Jawahar, M.S. 2004: Current trends in chemotherapy of tuberculosis Indian Journal of Medical Research 120(4): 398-417
Morstyn, G.; Schechter, G.P.; Ihde, D.C.; Carney, D.N.; Eddy, J.L.; Cohen, M.H.; Minna, J.D.; Bunn, P.A. 1984: Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness Cancer Treatment Reports 68(12): 1439-1446
Blettner, M.; Alexander, F.; Mason, T.; Preston-Martin, S.; Schlehofer, B. 1996: Synopsis of the international workshop on 'Risk Factors for Adult Leukaemias and Lymphomas', Heidelberg, Germany, 15-16 January 1996 Leukemia 10(10): 1662-1666
Golenkov, A.K.; Trifonova, E.V.; Kataeva, E.V.; Kil'diushevskiĭ, A.V.; Lutskaia, T.D.; Zariad'eva, E.A.; Nazarova, I.N.; Lukashina, M.N.; Zabotina, T.N.; Mikhaĭlova, I.N.; Inshakov, A.N.; Logacheva, N.P.; Baryshnikov, A.Iu. 2000: Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy Terapevticheskii Arkhiv 72(8): 38-41
Dreyfus, F.; Ribrag, V.; Leblond, V.; Ravaud, P.; Melle, J.; Quarre, M.C.; Pillier, C.; Boccaccio, C.; Varet, B. 1995: Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma Bone Marrow Transplantation 15(5): 707-711
Li, X.; Sun, W.; Jin, F.; Chen, S.; Zhong, Y.; Hu, Y.; Zhang, J.; An, N.; Shen, M.; Huang, Z. 2014: Clinical observation of DECP combination chemotherapy for relapsing and refractory multiple myeloma patients with extramedullary plasmacytomas Zhonghua Yi Xue Za Zhi 94(16): 1258-1260
Ludwig, H.; Fritz, E. 1981: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells Anticancer Research 1(6): 329-334